Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40495-020-00218-5 http://scihub22266oqcxt.onion/10.1007/s40495-020-00218-5 C7302922!7302922!32837851     free     free     free       Curr+Pharmacol+Rep 2020 ; 6 (4): 146-54 Nephropedia Template TP {{tp|p=32837851|t=2020. COVID-19 Drug Treatment in China |pdf=|usr=}}{{32837851}} gab.com Text COVID-19 Drug Treatment in China JO: Curr Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32837851 #FOAvip Purpose of Review: An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19. Recent Findings: At present, the strategy of new use of old drugs is mainly used to screen candidate drugs against the novel coronavirus (later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) and inhibit excessive immune response. Related research has made great progress. Summary: In this review, we summarize the drugs used for COVID-19 treatment in China based on the emerging basic and clinical data. It is hoped that this review will be useful to provide guidance for the prevention, treatment, and control of COVID-19. Twit Text FOAVip COVID-19 Drug Treatment in China ????Curr Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32837851 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32837851 #FOAvip English Wikipedia <ref>{{Cite pmid|32837851}}</ref> COVID-19 Drug Treatment in China #MMPMID32837851 Fan L; Jiang S; Yang X; Wang Z; Yang C Curr Pharmacol Rep 2020[]; 6 (4): 146-54 PMID32837851show ga Purpose of Review: An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19. Recent Findings: At present, the strategy of new use of old drugs is mainly used to screen candidate drugs against the novel coronavirus (later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) and inhibit excessive immune response. Related research has made great progress. Summary: In this review, we summarize the drugs used for COVID-19 treatment in China based on the emerging basic and clinical data. It is hoped that this review will be useful to provide guidance for the prevention, treatment, and control of COVID-19. äCOVID-19 Drug Treatment in China (epmc).pdf DeepDyve Pubget Overpricing